| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 51,037 | 51,787 | 48,169 | 47,814 | | Cost of Revenue | (71,781) | 36,165 | 35,616 | 35,839 | | | Gross Profit | 122,818 | 15,622 | 12,553 | 11,975 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 114,573 | 6,234 | 5,388 | 5,052 | | Non Recurring | 2,625 | 32 | 2 | 432 | | Others | (1,575) | 869 | 706 | 843 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 7,195 | 8,487 | 6,457 | 5,648 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2 | 2 | 3 | 10 | | Earnings Before Interest And Taxes | 7,197 | 8,489 | 6,460 | 3,805 | | Interest Expense | 93 | 113 | 88 | 121 | | Income Before Tax | 7,104 | 8,376 | 6,372 | 3,684 | | Income Tax Expense | 1,964 | 2,342 | 1,779 | 1,451 | | Minority Interest | (2,039) | (4,251) |
-
| (1,853) | | | | Net Income From Continuing Ops | 3,101 | 1,783 | 4,593 | 2,233 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,101 | 1,783 | 4,593 | 2,233 | | Preferred Stock And Other Adjustments |
-
| 1,839 | (1,839) |
-
| | | Net Income Applicable To Common Shares | $3,101 | $3,622 | $2,754 | $2,233 |
|
0.11% Nasdaq 0.00%
Income Statement
